<DOC>
	<DOC>NCT00560755</DOC>
	<brief_summary>Primary objective: To describe the safety profile of a second dose of ProQuad® manufactured with rHA when administered to children in their second year of life. Secondary objectives: To describe the safety profile of a first dose of ProQuad® manufactured with rHA when administered to children in their second year of life</brief_summary>
	<brief_title>ProQuad® rHA Safety</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<criteria>Healthy subject of either gender, Age from 12 to 22 months, Negative clinical history of infection with measles, mumps, rubella, varicella or zoster, Informed consent form signed by the parent(s) or by legal representative Parent(s) or legal representative able to attend all schedule visits with the subject and to understand and comply with the study procedures Recent (≤ 3 days) history of febrile illness Prior receipt of measles, mumps, rubella and/or varicella vaccination, either alone or in any combination Recent (≤ 30 days) exposure to measles, mumps, rubella, varicella or zoster Prior known sensitivity/allergy to any component of the vaccine Severe chronic disease, Blood dyscrasias, leukaemia, lymphomas of any type, or other malignant neoplasms affecting the haematopoietic and lymphatic system Any severe thrombocytopenia or any other coagulation disorder that would contraindicate intramuscular injection Humoral or cellular immunodeficiency, Current immunosuppressive therapy Family history of congenital or hereditary immunodeficiency Hereditary problems of fructose intolerance Known personal history of encephalopathy, seizure disorder or progressive, evolving or unstable neurological condition, Known active tuberculosis Recent (≤ 2 days) tuberculin test or scheduled tuberculin test through Visit 3 Receipt of immunoglobulins or bloodderived products in the past 150 days Receipt of an inactivated vaccine in the past 14 days Receipt of a live vaccine in the past 28 days</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>22 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention of: measles, mumps, rubella and varicella</keyword>
</DOC>